|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2000-6-5
|
|
pubmed:abstractText |
Treatment with the PDE-III inhibitor milrinone improves hemodynamics in patients with heart failure. We examined whether therapy with milrinone is safe and effective in critically ill patients with catecholamine-dependent heart failure and whether treatment with milrinone facilitates weaning from prolonged catecholamine therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0001-5172
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
403-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10757572-Aged,
pubmed-meshheading:10757572-Cardiotonic Agents,
pubmed-meshheading:10757572-Catecholamines,
pubmed-meshheading:10757572-Critical Illness,
pubmed-meshheading:10757572-Dobutamine,
pubmed-meshheading:10757572-Drug Therapy, Combination,
pubmed-meshheading:10757572-Female,
pubmed-meshheading:10757572-Heart Failure,
pubmed-meshheading:10757572-Hemodynamics,
pubmed-meshheading:10757572-Humans,
pubmed-meshheading:10757572-Male,
pubmed-meshheading:10757572-Middle Aged,
pubmed-meshheading:10757572-Milrinone,
pubmed-meshheading:10757572-Norepinephrine,
pubmed-meshheading:10757572-Phosphodiesterase Inhibitors,
pubmed-meshheading:10757572-Prospective Studies
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Milrinone therapy in catecholamine-dependent critically ill patients with heart failure.
|
|
pubmed:affiliation |
Department of Cardiology, University Clinic of Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
